Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Prevention of Episodic Migraine
NCT02593097Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Feb 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metformin in migraine (2 arms), sponsored by Mayo Clinic. Primary endpoint: Headache Days at 32 weeks. Started Feb 2016; status: completed.
02
Drugs
metformin
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02593097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02593097.